Stocks and Investing Stocks and Investing
Wed, April 26, 2023

David Hoang Initiated (ALNY) at Hold and Held Target at $220 on, Apr 26th, 2023


Published on 2024-10-28 03:03:45 - WOPRAI, David Hoang
  Print publication without navigation


David Hoang of SMBC Nikko, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold and Held Target at $220 on, Apr 26th, 2023.

David has made no other calls on ALNY in the last 4 months.



There are 11 other peers that have a rating on ALNY. Out of the 11 peers that are also analyzing ALNY, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $210 on, Tuesday, April 4th, 2023
  • Jessica Fung of "JP Morgan" Maintained at Hold with Decreased Target to $196 on, Friday, March 3rd, 2023
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $143 on, Monday, January 23rd, 2023


These are the ratings of the 8 analyists that currently disagree with David


  • William Pickering of "Bernstein" Initiated at Buy and Held Target at $243 on, Tuesday, March 21st, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $415 on, Friday, March 3rd, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Friday, February 24th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Friday, February 24th, 2023
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $249 on, Friday, February 24th, 2023
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $291 on, Friday, February 24th, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $265 on, Friday, February 24th, 2023
  • Michael King of "EF Hutton" Reiterated at Strong Buy and Held Target at $304 on, Friday, February 24th, 2023
Contributing Sources